Plain-English translation of NCT06638307 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage trial testing , a new type of cancer-fighting medication, in people with advanced breast cancer. Researchers want to learn whether this medication—given by itself or combined with another treatment called —can slow or stop the cancer's growth. The trial is enrolling about 240 participants to find out if the medication is safe and effective.
Advanced breast cancer is difficult to treat, especially when it stops responding to standard therapies. This trial exists because researchers believe this medication may help patients whose tumors have specific genetic changes and who have already tried other treatments without success.
You likely qualify if…
You likely don't qualify if…
If you join, you will take the new medication by mouth, either alone or combined with another pill. Some participants will be in a dose-finding phase where the research team carefully increases the dose to find the safest amount. You will have regular visits to the hospital or clinic for blood tests, scans, and check-ups to monitor how you're responding and watch for side effects.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States